- Report
- July 2023
- 109 Pages
Global
From €3500EUR$4,272USD£3,134GBP
- Report
- August 2024
- 90 Pages
Global
From €3500EUR$4,272USD£3,134GBP
- Report
- May 2022
- 48 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Report
- May 2022
- 38 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Report
- October 2023
- 80 Pages
Russia
From €1316EUR$1,500USD£1,139GBP
- Report
- October 2023
- 80 Pages
Poland
From €1316EUR$1,500USD£1,139GBP
- Report
- January 2025
- 132 Pages
Global
From €834EUR$950USD£721GBP
- Report
- January 2025
- 132 Pages
Global
From €834EUR$950USD£721GBP
The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids.
The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more